Ambev S.A. (NYSE:ABEV) shares traded 2.24% up during most recent session to reach at the closing price of $7.3. The stock exchanged hands 29.11 Million shares versus average trading capacity of 17.72 Million shares, yielding a market cap of $114.67 Billion. Wall Street analysts covering the stock are projecting that the stock will reach $7.07 within the next 52-weeks. The mean target projections are based on 8 opinions.

Taking a broader look brokerage firms’ analysts on the street with an expectant view have Ambev S.A. (NYSE:ABEV) high price target of $8.5 and with a conservative view have low price target of $5.7.

Barclays “Maintained” Ambev S.A. (NYSE:ABEV) in a research note issued to investors on 10/27/17 to Equal-Weight with price target of $7.

Additionally on 9/12/17 Credit Suisse “Upgrades” Ambev S.A. (NYSE:ABEV) to Outperform setting price target at $0 and on 11/10/16 JP Morgan “Upgrades” the stock to Overweight at $0. Furthermore on 11/03/16 Barclays “Initiates Coverage On” the stock to Equal-Weight.

On the other hand the company has Relative Strength Index (RSI 14) of 72.47 along with Average True Range (ATR 14) of 0.17, Consequently Ambev S.A. (NYSE:ABEV)’s weekly and monthly volatility is 2.12%, 2.37% respectively. The company’s beta value is at 0.

In terms of Buy, Sell or Hold recommendations, Ambev S.A. (NYSE:ABEV) has analysts’ mean recommendation of 2.6. This is according to a simplified 1 to 5 scale where 1 represents a Strong Buy and 5 a Strong Sell.

According to analysts Ambev S.A. (NYSE:ABEV)’s minimum EPS for the current quarter is at $0.05 and can go high up to $0.06. The consensus mean EPS for the current quarter is at $0.05 derived from a total of 3 estimates from the analysts who have weighed in on projected earnings. However the company reported $0.05 earnings per share for the same quarter during last year.

Previously Ambev S.A. (NYSE:ABEV) reported $0.09 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.08 by $0.01. The company posted an earnings surprise of 12.5%.

Ambev S.A. (NYSE:ABEV)’s revenue estimates for the current quarter are $3.69 Billion according to 1 number of analysts, for the current quarter the company has high revenue estimates of $3.69 Billion in contradiction of low revenue estimates of $3.69 Billion. For the current year the company’s revenue estimates are $15.83 Billion compared to low analyst estimates of $15.25 Billion and high estimates of $16.17 Billion according to 4 number of analysts.

Currently Ambev S.A. (NYSE:ABEV)’s shares owned by insiders are 0%, whereas shares owned by institutional owners are 7.75%. However the six-month change in the insider ownership was recorded 0%, as well as three-month change in the institutional ownership was recorded 0%.

Ambev S.A. (NYSE:ABEV) 52-week high price stands at $7.22 and low price stands at $5.30, its price distance from 52-week high is 1.11% while its distance from 52-week low price is 37.74%. The stock hit its 52-week high on 03/12/18, and 52-week low on 06/19/17.

Ambev S.A. (NYSE:ABEV)’s trailing twelve month revenues are $14.19 Billion, whereas its price to sales ratio for the same period is 8.08. Its book value per share for the most recent quarter is $0.93 while its price to book ratio for the same period is 7.89, as for as the company’s cash per share for the most recent quarter is $0, however its price to cash per share ratio for the same period is 0. The stock has 5 year expected PEG ratio of 7.92 whereas its trailing twelve month P/E ratio is 42.2.